BAX · Baxter International Inc
United States · RS rating 92 · As of 2026-10-14
| Price | 24.80 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 88 / 82 / 63 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 44 / 66 / 40 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | -2333.3% |
| Sales growth Q/Q | +4.9% |
| Distance from 52-week high | +12.5% |
| Market cap (USD) | $9.5B |